Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of TP US in Women With Prolapse

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03820089
Recruitment Status : Recruiting
First Posted : January 29, 2019
Last Update Posted : August 6, 2019
Sponsor:
Collaborator:
Cairo University
Information provided by (Responsible Party):
Aljazeera Hospital

Brief Summary:
Many women suffers from uterine and vaginal prolapse Usually they suffer from these symotoms in menopause

Condition or disease Intervention/treatment
Prolapse Diagnostic Test: Ultrasonography TP

Detailed Description:
The most common cause of pelvic organ prolapse is multiple pregnancy and multiparity

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 8 Weeks
Official Title: Evaluation of TP US Assesment of Women With Prolapse
Actual Study Start Date : January 29, 2019
Estimated Primary Completion Date : January 20, 2020
Estimated Study Completion Date : January 25, 2020

Intervention Details:
  • Diagnostic Test: Ultrasonography TP
    TP us will be made to the included women


Primary Outcome Measures :
  1. The number of women who will be properly diagnosed with prolapse by TP us [ Time Frame: within 2 months ]
    The accuracy of TP US in diagnosing the prolapse



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Females who have pelvic organ prolapse
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Women who complains from genital prolapse with previous normal deliveries
Criteria

Inclusion Criteria:

  • Women with history of normal delivery Age between 25 to 75 years

Exclusion Criteria:

  • women with cesarean deliveries

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03820089


Contacts
Layout table for location contacts
Contact: Mahmoud Alalfy, PhD 01002611058 mahmoudalalfy@ymail.com

Locations
Layout table for location information
Egypt
Algazeerah and Kasralainy hospital Recruiting
Giza, Egypt
Contact: Mahmoud Alalfy, master    +201002611058    mahmoudalalfy@ymail.com   
Contact: Ahmed Elgazzar, M.D    +201014005959      
Principal Investigator: Mahmoud Alalfy, master         
Sponsors and Collaborators
Aljazeera Hospital
Cairo University
Investigators
Layout table for investigator information
Principal Investigator: Mahmoud Alalfy, PhD Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Additional Information:

Layout table for additonal information
Responsible Party: Aljazeera Hospital
ClinicalTrials.gov Identifier: NCT03820089    
Other Study ID Numbers: prolapse
First Posted: January 29, 2019    Key Record Dates
Last Update Posted: August 6, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Prolapse
Pathological Conditions, Anatomical